Carla M. Lopes

2.4k total citations
54 papers, 1.7k citations indexed

About

Carla M. Lopes is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Carla M. Lopes has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmaceutical Science, 19 papers in Molecular Biology and 13 papers in Biomaterials. Recurrent topics in Carla M. Lopes's work include Advanced Drug Delivery Systems (18 papers), Advancements in Transdermal Drug Delivery (13 papers) and RNA Interference and Gene Delivery (11 papers). Carla M. Lopes is often cited by papers focused on Advanced Drug Delivery Systems (18 papers), Advancements in Transdermal Drug Delivery (13 papers) and RNA Interference and Gene Delivery (11 papers). Carla M. Lopes collaborates with scholars based in Portugal, Italy and United Kingdom. Carla M. Lopes's co-authors include Paulo Costa, José Manuel Sousa Lobo, Maria Helena Amaral, Maria Inês Teixeira, Ana Catarina Silva, Pedro Barata, João F. Pinto, Eliana B. Souto, Alessandra Rossi and Francesca Buttini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Pollution and International Journal of Molecular Sciences.

In The Last Decade

Carla M. Lopes

50 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carla M. Lopes Portugal 21 811 439 331 244 223 54 1.7k
Senshang Lin United States 18 1.0k 1.3× 311 0.7× 345 1.0× 152 0.6× 156 0.7× 47 1.6k
Virginia Merino Spain 29 1.4k 1.7× 538 1.2× 265 0.8× 251 1.0× 201 0.9× 109 2.7k
Rehab Nabil Shamma Egypt 26 1.2k 1.5× 379 0.9× 299 0.9× 221 0.9× 241 1.1× 71 2.3k
Muhammad Zaman Pakistan 23 739 0.9× 346 0.8× 297 0.9× 207 0.8× 146 0.7× 132 1.8k
Osama A. A. Ahmed Saudi Arabia 28 906 1.1× 551 1.3× 299 0.9× 147 0.6× 168 0.8× 111 2.1k
Avinash R. Tekade India 22 908 1.1× 384 0.9× 251 0.8× 158 0.6× 166 0.7× 45 1.5k
Aliaa Nabil ElMeshad Egypt 25 766 0.9× 247 0.6× 290 0.9× 180 0.7× 138 0.6× 57 1.5k
Bhupinder Singh India 30 1.3k 1.6× 520 1.2× 334 1.0× 198 0.8× 286 1.3× 72 2.4k
Mina Ibrahim Tadros Egypt 23 1.2k 1.5× 298 0.7× 272 0.8× 133 0.5× 147 0.7× 49 1.7k
Aifeng Zou China 7 843 1.0× 323 0.7× 547 1.7× 248 1.0× 149 0.7× 9 1.7k

Countries citing papers authored by Carla M. Lopes

Since Specialization
Citations

This map shows the geographic impact of Carla M. Lopes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla M. Lopes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla M. Lopes more than expected).

Fields of papers citing papers by Carla M. Lopes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla M. Lopes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla M. Lopes. The network helps show where Carla M. Lopes may publish in the future.

Co-authorship network of co-authors of Carla M. Lopes

This figure shows the co-authorship network connecting the top 25 collaborators of Carla M. Lopes. A scholar is included among the top collaborators of Carla M. Lopes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla M. Lopes. Carla M. Lopes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mota, Catarina Pinheiro, Ana Margarida Araújo, Eulália Pereira, et al.. (2025). Are all nanoplastics equally neurotoxic? Influence of size and surface functionalization on the toxicity of polystyrene nanoplastics in human neuronal cells. Environmental Pollution. 390. 127445–127445.
2.
Lopes, Carla M., et al.. (2024). Lipid Biomimetic Models as Simple Yet Complex Tools to Predict Skin Permeation and Drug–Membrane Biophysical Interactions. Pharmaceutics. 16(6). 807–807. 1 indexed citations
3.
Teixeira, Maria Inês, Carla M. Lopes, Maria Helena Amaral, & Paulo Costa. (2024). Navigating Neurotoxicity and Safety Assessment of Nanocarriers for Brain Delivery: Strategies and Insights. Acta Biomaterialia. 189. 25–56. 18 indexed citations
4.
Lopes, Carla M., et al.. (2024). Treatment Advances for Acne Vulgaris: The Scientific Role of Cannabinoids. Cosmetics. 11(1). 22–22. 8 indexed citations
5.
Lúcio, Marlene, Sérgio V. P. Barreira, José Catita, et al.. (2023). Nanostructured Lipid Carriers Enriched Hydrogels for Skin Topical Administration of Quercetin and Omega-3 Fatty Acid. Pharmaceutics. 15(8). 2078–2078. 14 indexed citations
6.
7.
Marques, Ana Camila, et al.. (2023). Acne Vulgaris Topical Therapies: Application of Probiotics as a New Prevention Strategy. Cosmetics. 10(3). 77–77. 10 indexed citations
8.
Adega, Filomena, et al.. (2023). Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers. Pharmaceutics. 15(4). 1317–1317. 16 indexed citations
9.
Teixeira, Maria Inês, Carla M. Lopes, Hugo Gonçalves, et al.. (2022). Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain. Pharmaceutics. 14(1). 185–185. 47 indexed citations
10.
Lopes, Carla M., et al.. (2022). Personalised Esomeprazole and Ondansetron 3D Printing Formulations in Hospital Paediatric Environment: I-Pre-Formulation Studies. Applied Sciences. 12(20). 10585–10585. 4 indexed citations
11.
Catita, José, Raúl Machado, Artur Ribeiro, et al.. (2021). Omega-3- and Resveratrol-Loaded Lipid Nanosystems for Potential Use as Topical Formulations in Autoimmune, Inflammatory, and Cancerous Skin Diseases. Pharmaceutics. 13(8). 1202–1202. 20 indexed citations
12.
Lopes, Carla M., et al.. (2021). Lipid Nanocarriers for Anti-HIV Therapeutics: A Focus on Physicochemical Properties and Biotechnological Advances. Pharmaceutics. 13(8). 1294–1294. 18 indexed citations
13.
Teixeira, Maria Inês, Maria Helena Amaral, Paulo Costa, Carla M. Lopes, & Dimitrios A. Lamprou. (2020). Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies. Pharmaceutics. 12(6). 542–542. 28 indexed citations
14.
Viseu, Teresa, et al.. (2018). A Systematic Review and Critical Analysis of the Role of Graphene-Based Nanomaterials in Cancer Theranostics. Pharmaceutics. 10(4). 282–282. 20 indexed citations
15.
Gonçalves, Hugo, et al.. (2018). A Molecular Biophysical Approach to Diclofenac Topical Gastrointestinal Damage. International Journal of Molecular Sciences. 19(11). 3411–3411. 24 indexed citations
16.
Lopes, Carla M., et al.. (2017). Phytotherapy and Nutritional Supplements on Breast Cancer. BioMed Research International. 2017. 1–42. 66 indexed citations
17.
Lopes, Carla M., et al.. (2016). Overview on gastroretentive drug delivery systems for improving drug bioavailability. International Journal of Pharmaceutics. 510(1). 144–158. 217 indexed citations
18.
Lopes, Carla M., Pedro Barata, & Rita Oliveira. (2015). Novel Delivery Systems for Anti-Allergic Agents: Allergic Disease and Innovative Treatments. Current Drug Delivery. 12(4). 382–396. 7 indexed citations
19.
Lopes, Carla M., José Manuel Sousa Lobo, João F. Pinto, & Paulo Costa. (2007). Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen. AAPS PharmSciTech. 8(3). E195–E202. 60 indexed citations
20.
Lopes, Carla M., José Manuel Sousa Lobo, João F. Pinto, & Paulo Costa. (2006). Compressed mini-tablets as a biphasic delivery system. International Journal of Pharmaceutics. 323(1-2). 93–100. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026